ZoomMed inc.

ZoomMed inc.

March 25, 2011 16:06 ET

ZoomMed Completes Its Private Placement Announced February 3, 2011

MONTREAL, QUEBEC--(Marketwire - March 25, 2011) - ZoomMed Inc. (TSX VENTURE:ZMD), announces that it has completed its private placement announced on February 3, 2011 (the "Private Placement"), with the closing of a second tranche for gross proceeds of $507,999 subscribed by Le Fonds d'Investissement RÉA II Natcan Inc. The aggregate size of the two Private Placement closings is $2,500,599. As part of this second closing, 3,277,419 units of ZoomMed were issued at a price of $0.155 per unit ("Unit"). Accordingly, the aggregate Units sold under the Private Placement is 16,132,902 Units. Each Unit consists of one common share of ZoomMed Inc. ("Common Share") and one-half warrant. Each whole warrant entitles the holder thereof to purchase one Common Share at an exercise price of $0.17 for a period of 24 months from the date of the closing of the financing. The Common Shares and warrants are subject to a mandatory hold period of 4 months and 1 day from the date of the closing.

Avenue Capital Markets CPVC Inc., a Montreal-based Exempt Market Dealer, acted as agent for the Private Placement and received a cash fee equivalent to 8% of the gross proceed of the Private Placement and an agent's option to purchase a number of Units, under the same terms and conditions as Units of the Private Placement, equivalent to 8% of the total number of Units sold.

The uses of proceeds of the Private Placement include the acquisition of Praxis Santé Inc. and additional working capital for ZoomMed Inc.

ZoomMed has received an advance income tax ruling from the "Ministère du Revenu du Québec" confirming that ZoomMed qualifies as a "qualified issuing corporation" and that the shares issued in regards of the Private Placement qualifies as "qualifying shares" for inclusion in a "Québec Stock Savings Plan II".

The Private Placement is subject to the final approval of the TSX Venture Exchange and other regulatory authorities.

About ZoomMed

ZoomMed's developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch™, IPhone™, IPad™, Google Android™, other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

For further information on ZoomMed visit our Web Site; www.zoommed.com.

About Avenue Capital Market

Avenue Capital Markets CPVC Inc. is an independent exempt market dealer dedicated to supporting the growth of small to mid cap companies located primarily in Québec. Avenue provides dynamic entrepreneurs with access to capital markets, corporate advisory services and experienced mentor networks.

For further information about Avenue Capital Market, please visit the Web Site; www.avenuecapitalmarkets.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information